OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent Advances in Nanomedicines for Multiple Sclerosis Therapy
Yujun Zeng, Zhiqian Li, Hongyan Zhu, et al.
ACS Applied Bio Materials (2020) Vol. 3, Iss. 10, pp. 6571-6597
Closed Access | Times Cited: 10

Showing 10 citing articles:

Enhancing autophagy in Alzheimer's disease through drug repositioning
Mehdi Eshraghi, Mazaher Ahmadi, Saeid Afshar, et al.
Pharmacology & Therapeutics (2022) Vol. 237, pp. 108171-108171
Closed Access | Times Cited: 70

Utilization of nanotechnology to surmount the blood-brain barrier in disorders of the central nervous system
Qian Luo, Jiaying Yang, Mei Yang, et al.
Materials Today Bio (2025) Vol. 31, pp. 101457-101457
Open Access | Times Cited: 1

Nanoparticles in Combating Neuronal Dysregulated Signaling Pathways: Recent Approaches to the Nanoformulations of Phytochemicals and Synthetic Drugs Against Neurodegenerative Diseases
Sajad Fakhri, Sadaf Abdian, Seyede Nazanin Zarneshan, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 299-331
Open Access | Times Cited: 33

Harnessing two-dimensional nanomaterials for diagnosis and therapy in neurodegenerative diseases: Advances, challenges and prospects
Samir Kumar Beura, Abhishek Panigrahi, Pooja Yadav, et al.
Ageing Research Reviews (2024) Vol. 94, pp. 102205-102205
Closed Access | Times Cited: 5

Unveiling the Potential of Cannabinoids in Multiple Sclerosis and the Dawn of Nano-Cannabinoid Medicine
Roua A. Nouh, Ahmed Kamal, Oluwaseyi Oyewole, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 241-241
Open Access | Times Cited: 5

Nanomedicine: Pioneering Advances in Neural Disease, Stroke and Spinal Cord Injury Treatment
Borish Loushambam, Sangeeta Yanglem, Venkatraman Krishnaswami, et al.
Neuroglia (2025) Vol. 6, Iss. 1, pp. 9-9
Open Access

Nanomedicines for high‑intensity focused ultrasound cancer treatment and theranostics (Review)
Qinyun Zheng, Bingxin Xia, Xianlong Huang, et al.
Experimental and Therapeutic Medicine (2023) Vol. 25, Iss. 4
Open Access | Times Cited: 6

Recent advances in development of nanomedicines for multiple sclerosis diagnosis
Qin Zhang, Xinghang Dai, Hu Zhang, et al.
Biomedical Materials (2021) Vol. 16, Iss. 2, pp. 024101-024101
Closed Access | Times Cited: 11

Novel Approaches in the Immunotherapy of Multiple Sclerosis: Cyclization of Myelin Epitope Peptides and Conjugation with Mannan
John Matsoukas, Irene Ligielli, Christos T. Chasapis, et al.
Brain Sciences (2021) Vol. 11, Iss. 12, pp. 1583-1583
Open Access | Times Cited: 9

Nanotechnology: A Promising Approach in Nerve Regeneration
Atul Chaskar, Namrah Azmi, Abhishekh Tiwari, et al.
Current Nanoscience (2022) Vol. 19, Iss. 3, pp. 305-321
Closed Access | Times Cited: 1

Page 1

Scroll to top